[go: up one dir, main page]

NO960632L - Nye bis-naftalimider for behandling av kreft - Google Patents

Nye bis-naftalimider for behandling av kreft

Info

Publication number
NO960632L
NO960632L NO960632A NO960632A NO960632L NO 960632 L NO960632 L NO 960632L NO 960632 A NO960632 A NO 960632A NO 960632 A NO960632 A NO 960632A NO 960632 L NO960632 L NO 960632L
Authority
NO
Norway
Prior art keywords
cancer
treatment
naphthalimides
new bis
formula
Prior art date
Application number
NO960632A
Other languages
English (en)
Other versions
NO305554B1 (no
NO960632D0 (no
Inventor
Gerhard Keilhauer
Cynthia Romerdahl
Miguel Fernandez Brana
Xiao-Dong Qian
Peter Bousquet
Jose Maria Castellano Berlanga
Marina Moran Moset
Maria Jesus Perez De Vega
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO960632L publication Critical patent/NO960632L/no
Publication of NO960632D0 publication Critical patent/NO960632D0/no
Publication of NO305554B1 publication Critical patent/NO305554B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO960632A 1993-08-18 1996-02-16 Nye bis-naftalimider og farmas°ytisk blanding for behandling av kreft NO305554B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10894993A 1993-08-18 1993-08-18
PCT/EP1994/002621 WO1995005365A1 (en) 1993-08-18 1994-08-08 New bis-naphthalimides for the treatment of cancer

Publications (3)

Publication Number Publication Date
NO960632L true NO960632L (no) 1996-02-16
NO960632D0 NO960632D0 (no) 1996-02-16
NO305554B1 NO305554B1 (no) 1999-06-21

Family

ID=22324990

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960632A NO305554B1 (no) 1993-08-18 1996-02-16 Nye bis-naftalimider og farmas°ytisk blanding for behandling av kreft

Country Status (28)

Country Link
US (3) US5616589A (no)
EP (1) EP0714387B1 (no)
JP (1) JPH09501662A (no)
KR (1) KR960703863A (no)
CN (1) CN1039414C (no)
AT (1) ATE166647T1 (no)
AU (1) AU677696B2 (no)
BR (2) BR9407257A (no)
CA (1) CA2169059A1 (no)
CZ (1) CZ34296A3 (no)
DE (1) DE69410614T2 (no)
DK (1) DK0714387T3 (no)
ES (1) ES2116612T3 (no)
FI (1) FI960658A7 (no)
HR (1) HRP940458B1 (no)
HU (1) HU219232B (no)
IL (1) IL110460A (no)
NO (1) NO305554B1 (no)
NZ (1) NZ271374A (no)
PH (1) PH31395A (no)
PL (1) PL313078A1 (no)
RU (1) RU2138484C1 (no)
SG (1) SG64906A1 (no)
SI (1) SI9420053A (no)
TW (1) TW408112B (no)
UA (1) UA42733C2 (no)
WO (1) WO1995005365A1 (no)
ZA (1) ZA946196B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703089A (en) * 1994-04-28 1997-12-30 Knoll Aktiengesellschaft Dihydrodibenzisoquinolinediones
NZ335291A (en) * 1996-10-21 2001-02-23 Allelix Biopharma Neurotrophin antagonist compositions
US6420344B1 (en) 1999-03-16 2002-07-16 The Regents Of The University Of California Glycosylated polyamines
US6531454B1 (en) 1999-03-16 2003-03-11 The Regents Of The University Of California Glycosylated polyamines and methods of use therefor
US6468990B1 (en) * 1999-05-17 2002-10-22 Queen's University At Kingston Method of inhibiting binding of nerve growth factor to p75 NTR receptor
US6492380B1 (en) * 1999-05-17 2002-12-10 Queen's University At Kingston Method of inhibiting neurotrophin-receptor binding
AU2001240054B2 (en) 2000-03-07 2005-08-11 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 1,8-Naphthalimide Imidazo[4,5,1-de]acridones with Anti-Tumor Activity
ATE506079T1 (de) 2003-11-05 2011-05-15 Photobiomed Corp Verbindungsgewebe und vernetzungsproteine mit naphthalimid-verbindungen
AU2005238096A1 (en) * 2004-05-05 2005-11-10 Unibioscreen S.A. Naphthalimide derivatives, methods for their production and pharmaceutical compositions therefrom
US20070134243A1 (en) * 2004-12-01 2007-06-14 Gazzard Lewis J Antibody drug conjugates and methods
US7947839B2 (en) 2004-12-01 2011-05-24 Genentech, Inc. Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
WO2006060533A2 (en) 2004-12-01 2006-06-08 Genentech, Inc. Conjugates of 1, 8-bis-naphthalimides with an antibody
CA2622574A1 (en) 2005-09-15 2007-03-22 Painceptor Pharma Corporation Methods of modulating neurotrophin-mediated activity
US8420665B2 (en) 2008-01-11 2013-04-16 Northwestern University Anti-cancer compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3535496A1 (de) * 1985-10-04 1987-04-16 Bayer Ag Verfahren zur fluoreszenzloeschung und neue kationische naphthalin-peri-dicarbonsaeureimid-derivate
DE3707651A1 (de) * 1987-03-10 1988-09-22 Knoll Ag Bis-naphthalimide, ihre herstellung und verwendung
US5086052A (en) * 1987-07-17 1992-02-04 Abbott Laboratories Substituted 1,4,5,6-tetrahydro-2H-pyridazin-3-one and -3-thione compounds having lipoxygenase inhibitory activity
US5086059A (en) * 1990-06-07 1992-02-04 Du Pont Merck Pharmaceutical Company Bis-naphthalimides as anticancer agents
US5206249A (en) * 1991-03-27 1993-04-27 Du Pont Merck Pharmaceutical Company Bis-naphthalimides containing amino-acid derived linkers as anticancer agents
WO1993012092A1 (en) * 1991-12-11 1993-06-24 The Du Pont Merck Pharmaceutical Company Highly water soluble bis-naphthalimides useful as anticancer agents
DE4232739A1 (de) * 1992-09-30 1994-03-31 Knoll Ag Neue asymmetrisch substituierte bis-Naphthalimide

Also Published As

Publication number Publication date
HUT73529A (en) 1996-08-28
HRP940458B1 (en) 2000-02-29
DK0714387T3 (da) 1998-10-12
HU219232B (en) 2001-03-28
WO1995005365A1 (en) 1995-02-23
CA2169059A1 (en) 1995-02-23
US5981753A (en) 1999-11-09
CZ34296A3 (en) 1996-08-14
US5789418A (en) 1998-08-04
BR9407257A (pt) 1996-09-24
PL313078A1 (en) 1996-05-27
JPH09501662A (ja) 1997-02-18
CN1132506A (zh) 1996-10-02
IL110460A (en) 2001-01-11
SI9420053A (en) 1996-08-31
AU7498494A (en) 1995-03-14
NZ271374A (en) 1997-05-26
SG64906A1 (en) 1999-05-25
US5616589A (en) 1997-04-01
HRP940458A2 (en) 1997-06-30
FI960658L (fi) 1996-02-14
ES2116612T3 (es) 1998-07-16
BR1100143A (pt) 2000-03-14
FI960658A0 (fi) 1996-02-14
EP0714387A1 (en) 1996-06-05
EP0714387B1 (en) 1998-05-27
IL110460A0 (en) 1994-10-21
RU2138484C1 (ru) 1999-09-27
PH31395A (en) 1998-10-29
ZA946196B (en) 1996-02-19
TW408112B (en) 2000-10-11
FI960658A7 (fi) 1996-02-14
NO305554B1 (no) 1999-06-21
DE69410614D1 (de) 1998-07-02
DE69410614T2 (de) 1998-09-24
UA42733C2 (uk) 2001-11-15
AU677696B2 (en) 1997-05-01
NO960632D0 (no) 1996-02-16
CN1039414C (zh) 1998-08-05
KR960703863A (ko) 1996-08-31
HU9600360D0 (en) 1996-04-29
ATE166647T1 (de) 1998-06-15

Similar Documents

Publication Publication Date Title
NZ244021A (en) Benzylthiazolidinedione derivatives, preparation and pharmaceutical compositions thereof
NO180583C (no) Arylsulfonamido-substituerte hydroksamsyrer, farmasöytiske preparater inneholdende forbindelsene og anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
NO921835L (no) Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav
DE59000750D1 (de) Arzneimittel, enthaltend di-tert.-butylhydroxyphenyl-derivate sowie neue derivate.
RU94036448A (ru) Производные галантамина и фармацевтическая композиция
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
NO960632D0 (no) Nye bis-naftalimider for behandling av kreft
ES8207169A1 (es) Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad.
ATE203246T1 (de) Dialkyltiacumicine
DE69330601D1 (de) Serotoninergische ergolin derivate
ES2104682T3 (es) Fluor-compuestos.
AU5390900A (en) Potassium channel blocking agents
ES2098338T3 (es) Heteroarilmetilbencenos.
ATE100463T1 (de) Renin-hemmende aminooligohydroxy-derivate.
SE9203824D0 (sv) Benzofuranylimidazole derivatives a process for the preparation and therapeutical compositions containing the same
FI944120A0 (fi) Kinoliiniyhdisteet
IL114646A0 (en) Method of inhibiting leukotriene biosynthesis

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2003